Phase 4 N=104 Body and Social Behavior
Psychology, Social · Inflammation · Defeat, Social
Primary: IL-6 Levels 24 Hours After Vaccine — 0.40; 0.23 log pg/mL — p=<0.001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=14 Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
Osteonecrosis
Primary: Signal to Noise Ratio (SNR) — 33.82; 129.56 dB — p=0.002
Phase 4 N=2 Study for Patients Previously Treated in Avapritinib Clinical Trials
Gastrointestinal Stromal Tumors
Primary: Number of Participants With Adverse Events of Special Interest (AESIs) — 0 Participants
Phase 4 N=102 Exparel for Total Shoulder Arthroplasty
Total Shoulder Arthroplasty
Primary: Pain Score in the 24 Hours After Surgery — 0.76; 3.37 score on a scale
Phase 4 N=202 A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma
Asthma
Primary: Change From Baseline to Week 12 in Sleep Disturbance Score Using the Asthma Sleep Disturbance Questionnaire (ASDQ) — -0.88; -0.81 Score on a scale — p=0.512
Phase 4 N=90 Physiologic Approach to Sodium Supplementation in Premature Infants
Postnatal Growth Disorder
Primary: Change in Somatic Growth (Weight) — 0.04; 0.16 score on a scale — p=0.162
Phase 4 N=103 Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
Primary: Adverse Events of Special Interest (AESI) Including Arrhythmias (Atrial Fibrillation), Anaemia, Hypertension, Bleeding, Infections — 0; 0 Events
Phase 4 N=100 Pecto-Intercostal Fascial Plane Block Study
Cardiac Surgery · Opioid Use, Unspecified
Primary: Total Opioid Consumption 72 Hours Post-operatively — 165.00; 205.05 morphine milligram equivalents
Phase 4 N=16 Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence.
Addiction Opiate
Primary: Number of Participants With Dose Limiting Toxicities — 0; 0; 0; 0 participants
Phase 4 N=26 Effects of Genotype on Resting State Connectivity During Methamphetamine Administration
Methamphetamine-dependence
Primary: Functional Connectivity During Resting State Magnetic Resonance Imaging (MRI) — 0.91; 0.52; 0.54; 0.32 Fisher's Z-score
Phase 4 N=59 Effect of Combined Morphine and Duloxetine on Chronic Pain
Chronic Low Back Pain · Chronic Neck Pain
Primary: Overall Opioid Dose (Morphine-equivalent Dose in mg) — 19.6; 19.6; 19.6 mg
Phase 4 N=192 Povidone-Iodine for Nasal Decolonization
Surgical Wound Infection · Preoperative Care · Methicillin-Resistant Staphylococcus Aureus
Primary: Change in S. Aureus/MRSA Colony Forming Units (CFU) in Nasal Swab Specimen After Treatment in Patients Who Presented With a Positive for S. Aureus/MRSA…
Phase 4 N=196 To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients
Type 2 Diabetes Mellitus
Primary: Adverse Events (AEs) Including Serious Adverse Events (SAEs), AEs Leading to Discontinuation (DAE), and Adverse Events of Special Interest — 40; 0; 0; 4 events
Phase 4 N=100 Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC
Unresectable Non-small Cell Lung Cancer (NSCLC)
Primary: Number and Proportion of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs of Special Interest (AESI) — 74; 21; 74; 21 Participants
Phase 4 N=23 Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)
Eosinophilic Esophagitis
Primary: Percent of Patients in Remission at One Year as Measured by EGD — 5; 1 Participants — p=0.57